20 Dec 2022 by admin in UncategorizedComments Kira Pharmaceuticals Announces Clearance to Initiate Phase 2 Evaluation of KP104 in IgA Nephropathy (IgAN) and Complement 3 Glomerulopathy (C3G) in China and Australia
09 Dec 2022 by admin in UncategorizedComments Arcellx And Kite Announce Strategic Collaboration To Co- Develop And Co-Commercialize Late-Stage Clinical CART- DdBCMA In Multiple Myeloma
02 Dec 2022 by admin in UncategorizedComments INNOFORCE OPENS GMP MANUFACTURING FACILITY & CORPORATE HEADQUARTERS IN HANGZHOU, CHINA TO PROVIDE CDMO SERVICES FOR GLOBAL SUPPLY OF RNA, CELL & GENE THERAPIES
30 Nov 2022 by admin in UncategorizedComments Kira Pharmaceuticals Announces First Cohort of Patients Dosed
30 Nov 2022 by admin in UncategorizedComments Adicet Bio Appoints Nancy Boman, M.D., Ph.D., as Senior Vice President and Chief Regulatory Officer
17 Nov 2022 by admin in UncategorizedComments Laronde Appoints Pablo J. Cagnoni as Chief Executive Officer
15 Nov 2022 by admin in UncategorizedComments NextCure and LegoChem Biosciences Enter into Collaboration and Co-Development Agreement to Develop Antibody Drug Conjugates
14 Nov 2022 by admin in UncategorizedComments Syros Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides a Corporate Update
14 Nov 2022 by admin in UncategorizedComments Arcellx Reports Third Quarter 2022 Financial Results And Business Progress
08 Nov 2022 by admin in UncategorizedComments Tempest Reports Third Quarter 2022 Financial Results and Provides Business Update
